High-dose risankizumab induces rapid, deep skin clearance in moderate-to-severe psoriasis and sustains remission long after treatment stops, alongside a significant reduction in pathogenic tissue-resident memory T cells within former lesions, supporting its potential as a durable therapeutic option.

Published 1 day ago
Source: reddit.com

Categories

science